Bradley Christian

Dr. Bradley Christian

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Neurobiology of Aging
Verified
Journal Article
Closed access
KSKate E. Sprecher
Kate E. Sprecher
BBBarbara B. Bendlin
Barbara B. Bendlin
ARAnnie M. Racine
Annie M. Racine
OOOzioma C. Okonkwo
Ozioma C. Okonkwo
BCBradley Christian
Bradley Christian
RBRuth M. Benca
Ruth M. Benca

16 June 2010 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
BCBradley Christian
Bradley Christian
NVNicholas T. Vandehey
Nicholas T. Vandehey
JFJohn M. Floberg
John M. Floberg
CMCharles A. Mistretta
Charles A. Mistretta
HighlY constrained backPRojection (HYPR) is a promising image-processing strategy with widespread application in time-resolved MRI that is also well suited for PET applications requiring time series data. The HYPR technique involves the creation of a composite image from the entire time series. The individual time frames then provide the basis for weighting matrices of the composite. The signal-to-noise ratio (SNR) of the individual time frames can be dramatically improved using the high SNR of the composite image. In this study, we introduced the modified HYPR algorithm (the HYPR method constraining the backprojections to local regions of interest [HYPR-LR]) for the processing of dynamic PET studies. We demonstrated the performance of HYPR-LR in phantom, small-animal, and human studies using qualitative, semiquantitative, and quantitative comparisons. The results demonstrate that significant improvements in SNR can be realized in the PET time series, particularly for voxel-based analysis, without sacrificing spatial resolution. HYPR-LR processing holds great potential in nuclear medicine imaging for all applications with low SNR in dynamic scans, including for the generation of voxel-based parametric images and visualization of rapid radiotracer uptake and distribution.

13 June 2015 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PLPatrick Lao
Patrick Lao
TBTobey J. Betthauser
Tobey J. Betthauser
AHAnsel T. Hillmer
Ansel T. Hillmer
JPJulie C. Price
Julie C. Price
WKWilliam E. Klunk
William E. Klunk
BCBradley Christian
Bradley Christian

1 May 2006 in NeuroImage
Verified
Journal Article
Closed access
BCBradley Christian
Bradley Christian
DLDouglas S. Lehrer
Douglas S. Lehrer
BSBingzhi Shi
Bingzhi Shi
TNTanjore K. Narayanan
Tanjore K. Narayanan
PSPamela S. Strohmeyer
Pamela S. Strohmeyer
JMJoseph C. Mantil
Joseph C. Mantil

1 March 2021 in NeuroImage
Verified
Journal Article
Open access
MZMatthew D. Zammit
Matthew D. Zammit
DTDana L. Tudorascu
Dana L. Tudorascu
CLCharles M. Laymon
Charles M. Laymon
SHSigan L. Hartley
Sigan L. Hartley
SZShahid Zaman
Shahid Zaman
BCBradley Christian
Bradley Christian
Adults with Down syndrome (DS) are predisposed to Alzheimer's disease (AD) and reveal early amyloid beta (Aβ) pathology in the brain. Positron emission tomography (PET) provides an in vivo measure of Aβ throughout the AD continuum. Due to the high prevalence of AD in DS, there is need for longitudinal imaging studies of Aβ to better characterize the natural history of Aβ accumulation, which will aid in the staging of this population for clinical trials aimed at AD treatment and prevention. Adults with DS (N = 79; Mean age (SD) = 42.7 (7.28) years) underwent longitudinal [C-11]Pittsburgh compound B (PiB) PET. Global Aβ burden was quantified using the amyloid load metric (AβL). Modeled PiB images were generated from the longitudinal AβL data to visualize which regions are most susceptible to Aβ accumulation in DS. AβL change was evaluated across Aβ(-), Aβ-converter, and Aβ(+) groups to assess longitudinal Aβ trajectories during different stages of AD-pathology progression. AβL change values were used to identify Aβ-accumulators within the Aβ(-) group prior to reaching the Aβ(+) threshold (previously reported as 20 AβL) which would have resulted in an Aβ-converter classification. With knowledge of trajectories of Aβ(-) accumulators, a new cutoff of Aβ(+) was derived to better identify subthreshold Aβ accumulation in DS. Estimated sample sizes necessary to detect a 25% reduction in annual Aβ change with 80% power (alpha 0.01) were determined for different groups of Aβ-status. Modeled PiB images revealed the striatum, parietal cortex and precuneus as the regions with earliest detected Aβ accumulation in DS. The Aβ(-) group had a mean AβL change of 0.38 (0.58) AβL/year, while the Aβ-converter and Aβ(+) groups had change of 2.26 (0.66) and 3.16 (1.34) AβL/year, respectively. Within the Aβ(-) group, Aβ-accumulators showed no significant difference in AβL change values when compared to Aβ-converter and Aβ(+) groups. An Aβ(+) cutoff for subthreshold Aβ accumulation was derived as 13.3 AβL. The estimated sample size necessary to detect a 25% reduction in Aβ was 79 for Aβ(-) accumulators and 59 for the Aβ-converter/Aβ(+) group in DS. Longitudinal AβL changes were capable of distinguishing Aβ accumulators from non-accumulators in DS. Longitudinal imaging allowed for identification of subthreshold Aβ accumulation in DS during the earliest stages of AD-pathology progression. Detection of active Aβ deposition evidenced by subthreshold accumulation with longitudinal imaging can identify DS individuals at risk for AD development at an earlier stage.

22 October 2010 in Synapse
Verified
Journal Article
Closed access
PDF file
DWD.W. Wooten
D.W. Wooten
JMJ.D. Moraino
J.D. Moraino
AHA.T. Hillmer
A.T. Hillmer
Jonathan W EngleJonathan W Engle
Jonathan W Engle
ODO.J. DeJesus
O.J. DeJesus
BCBradley Christian
Bradley Christian